D-Cycloserine is primarily used in the treatment of tuberculosis, particularly for cases that are resistant to standard therapies. It works by inhibiting the synthesis of bacterial cell walls, thereby stopping the growth of the bacteria. Beyond its antimicrobial applications, D-Cycloserine has been explored in the field of psychiatry. It acts as a partial agonist at the NMDA receptor, which is involved in learning and memory. This property has led to its use in clinical trials for treating psychiatric conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD). Additionally, it has shown promise in enhancing the effectiveness of exposure therapy for phobias and other anxiety-related disorders. In neuroscience research, D-Cycloserine is utilized to study the role of NMDA receptors in synaptic plasticity and cognitive functions. Its dual role in both medical treatment and psychological therapy makes it a versatile compound in clinical and research settings.